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INTRODUCTION
The objective of this study is to review literature addressing the 
advancements in the use of bone morphogenetic protein (BMP) 
on bone tissue repair and its mechanisms of action in the injured 
tissue.
BMPs are glycoproteins accounting for the recruitment of osteo-
progenitor cells to sites of bone formation(1).
For Bowers and Reddi(2) BMPs are proteins found in high amounts 
in bone tissues and are considered as responsible for inductive 
and regenerative abilities of demineralized bone grafts used in 
periodontal therapy.
DEVELOPMENT
The first inquiries about processes determining bone neofor-
mation, in sites deprived of bone tissue, were based on Urist’s 
finding. For him, a central factor could be responsible for that 
effect. That factor was reported as a substance inducing bone 
formation, present at bone matrix. Inductor cells and inducted 
cells were provided by host and those inductor cells would be 
descendants of histiocytes and perivascular conjunctive tissue 
cells. The term osteoinduction was designated to an essential 
principle of bone regeneration triggered by the action of bone 
morphogenetic proteins(3,4).
From an aminoacids sequence with a highly purified extract, 
Wozney et al.(5) obtained DNA clones containing each protein’s 
code. At total, they obtained 8 proteins - 7 of them are named as 
BMPs and present similar structural characteristics. By purifying 
the BMP present in bovine bone, details were revealed about the 
identification and molecular cloning of factors with BMP activity. By 
isolating many polypeptides, the authors determined the sequence 
of many aminoacids and synthesized an oligonucleotide probe. 
Thus, 2-9 BMPs (BM-2 to BMP-9) cloning was possible, which 
are members of the family of the transformer growth factor beta 
(TGF-`). The members of this superfamily may exert an inhibiting 
or stimulating effect on cells, depending on the stage of cellular 
differentiation in which they come to act(6).
According to Wozney(7), the osteoinductive activity of bone mor-
phogenetic proteins added to its presence in bone tissue suggest 
that they are important regulators in bone repair process and may 
be involved in such tissues’ maintenance. They are part of the 
family of the transformer growth factor beta (TGF-`) and includes 
a subfamily based in its aminoacid sequences, and reported that 
the BMPs may present themselves in two forms: a) bone morpho-
genetic proteins derived from the bone; b) recombining human 
bone morphogenetic proteins (rhBMP).
Kawai and Urist(8) analyzed proteins extracted from bovine dental 
tissues regarding osteoinductive activity and suggested that 
those proteins were comparable to bovine bone morphogenetic 
proteins.
Wang et al.(9) and Wozney et al.(10), stated that the pure recombi-
ning human bone morphogenetic protein - two (rhBMP-2), when 
implanted in high doses, can induce bone formation. 
The BMP effect on repairing dentine formation was examined 
by Nakashima when he implanted such mentioned bone mor-
phogenetic proteins over dental pulps amputated from animals. 
The author verified that those proteins stimulated the mitosis of 
mesenchymal cells and induced the differentiation of osteodenti-
nocytes. The resulting osteodentine may play a role on osteoblasts 
differentiation(11).
Lyons et al.(12) suggested that the BMP-2 plays multiple functions 
in the morphogenesis and pattern of vertebrate embryos. By using 
in situ hybridization, they showed that BMP-2’s RNA manifest itself 
in a number of embryonary tissues, such as: epithelial, mesenchy-
mal, and from skeletal system. Thus, BMP-2’s RNA was found in 
organs, such as: heart, pilary follicles, dental button, craniofacial 
mesenchyma, and other sites.
Bowers et al.(13) compared the use of osteogenia (BMP-3) asso-
ciated to dry and frozen demineralized graft (DFDBA) with bone 
matrix (DFDBA), with bovine tendon alone and with bovine tendon 
combined with osteogenin in the increase of periodontal regene-
rative processes in human infrabone defects. They concluded that 
osteogenin combined with DFDBA significantly increases the rege-
neration of the display of a new insertion and tissue components, 
such as: cement, alveolar bone, and periodontal ligament.
For Toriumi and Robertson(14),one of the most important factors that 
can determine the success or the failure of inductor bone grafts in 
reconstructive surgeries is the carrier material efficiency. The ideal 
carrier should increase the exposure of host’s tissues to the gro-
wth substance and assure a uniform distribution, not allowing the 
implanted material to exceed site boundaries. The carrier should 
be absorbed as bone formation occurs. Additionally, it must be 
safe, biodegradable, and formulated to allow appropriate sizes 
and shapes to the graft.
SUMMARY
This literature review study addresses the progresses of the use of 
the bone morphogenetic protein (BMP) for repairing the bone tissue 
and its mechanisms of action in the injured tissue. The BMPs are 
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pleiotropic molecules that are involved in the chemotaxis, mitosis 
and differentiation of mesenchymal cells in the bone tissue.
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Saller and Kolb(15), after a review of relevant success of bone 
morphogenetic proteins in buccomaxillofacial and orthopaedic 
surgeries, demonstrated the efficiency of the purificate, that is, of 
the BMPs concentrate in bone induction in areas with apparently 
lost implants.
Graves and Cochran(16) described the family of the five growth 
factors having potential to induce periodontal regeneration when 
in contact with osteoblasts and periodontal ligament cells in vitro 
and in vivo. In this case, they included the platelet-derived growth 
factor (PDGF), the fibroblasts growth factor (FGF), the transforming 
growth factor beta (TGF-`), the insulin-like growth factor (IGF) 
and the bone morphogenetic proteins. The authors also reported 
the existence of the following BMPs: BMP-4, BMP-5, BMP-6, and 
BMP-7. From BMP-2 to BMP-7, the presence of molecular struc-
tures of members of the transforming growth factor beta (TGF-`)
family occurs.
Ripamonti and Reddi(17) stated that, additionally to their functions 
on post-fetal osteogenesis, the BMPs may play multiple roles in 
embryogenic and organogenic development, including skeleto-
genesis, craniofacial and dental tissues development.
Hughes et al.(18) demonstrated through in vitro tests with rats’ 
osteoprogenitor cells that the BMP-6, BMP-4 and BMP-2 can sti-
mulate osteoblasts differentiation. They suggested that an early 
osteoprogenitor cell is an important cell for BMPs action during 
bone induction.
Nevins et al.(19) analyzed the efficacy, safety, and technical ease 
in inducing bone formation in dogs’ bone defects, and maxillary 
sinus’ membrane lifting with the use of an absorbable collagen 
sponge impregnated with rhBMP-2. Results suggested substantial 
bone formation and, in 68% of treated bone defects, a new bone 
was formed.
Lee(20) reviewed the biological basis of bone morphogenetic pro-
teins and their implications on oral reconstruction. He reported that 
the materials used as bone grafts could offer osteoconduction in 
the presence of a physical or support matrix, thereby occurring 
a new bone deposing. He defined osteoinduction as the act or 
process of stimulating osteogenesis, thus the osteoblast would 
help the bone matrix.
Ripamonti and Duneas(21) conducted a review on tissue morpho-
genesis and on the regeneration promoted by bone morphoge-
netic proteins. The authors postulated that the post-birth tissue 
regeneration mimics events occurring during the usual course 
of development and tissue regeneration, similarly regulated by a 
distinct family of morphogenesis. Thus, we would have all BMPs 
acting on the development of tissues and organs, some of them 
with a higher number of specific proteins, such as in kidney 
(BMP-3 and BMP-7), in central  and peripheral nervous system, 
liver (BMP-9), lungs (BMP-3 and BMP-4), heart, teeth, gonads, 
skin and liver (BMP-9). 
Lynch et al.(22,23) said that an occurrence of slow release of rhBMP-2, 
with fast systemic washout, associated to other pharmacokinetic 
studies, such as absorption, distribution, metabolism and excretion 
confirmed he absence of toxic effects for rhBMP-2. BMPs ability to 
induce bone formation through endochondral or intramembranous 
process is not clear yet. They suggested that a number of factors 
involved, such as applied BMP dose, implantation site, responses 
of cells at implant site, vascularization and nature of the carrier 
material would be the responsible factors for determining the kind 
of ossification.
Ripamonti and Tasker(24), stated that tissue regeneration enginee-
ring has been rapidly increasing in the field of cell and molecular 
biology. The great recent processes in elucidating molecular 
biology of the BMPs and their receptors helped on the promotion 
and understanding of a wide field for future use of BMPs.  
Minamide et al.(25), evaluated two carry systems for BMPs. The first 
was a porous structure called true bone ceramics and the other 
was the type-I collagen. Results showed that the first presented 
its porous structure filled with bone and was more efficient than 
the type-I collagen, which promoted a fast growth with strong 
bone formation.
CONCLUSION
BMPs present many possibilities of application in odontology, 
orthopaedics and in other knowledge areas involving cell diffe-
rentiation due to the fact that they represent a distinct group of 
inducing factors, able to stimulate source-mesenchymal cells 
differentiation in specialized cells, inducing bone neoformation 
and bone tissue repair.  
The indications for BMPs use are mainly associated to great bone 
losses, resulting from development abnormalities, as well as bone 
defects caused by some trauma in bone structures, infectious and 
inflammatory diseases.
A definitive evaluation on the clinical use of BMPs will only be possi-
ble after all those different factors influencing tissue repair are eluci-
dated, along with the development of an appropriate carrier system, 
which should assure a more adequate treatment protocol.
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